Identification and characterization of PS-GAP as a novel regulator of caspase-activated PAK-2
about
The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functionsGenome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRAProstasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin.Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic eventsGRAF1 promotes ferlin-dependent myoblast fusionSignal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death.PAK signaling in oncogenesis.Stimulation of the cell death response by PAK-2p34Regulation of PAK-2p34 activity by PS-GAP/RHG10Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.Rho GTPase-activating protein 10 (RHG10) interacts with caspase-activated PAK-2p34Interaction of PAK-2p34 with RGH10/ PS-GAP results in accumulation of PAK-2p34 in the perinuclear regionFunctional PAK-2 knockout and replacement with a caspase cleavage-deficient mutant in mice reveals differential requirements of full-length PAK-2 and caspase-activated PAK-2p34.
P2860
Q28593750-7CA4728C-8FEB-442C-AD8D-A22940E77354Q28943344-41A2F27A-44F7-4300-9CF7-B1D2D83BA646Q33705325-22A82595-4C78-40C9-9502-D156412C1CB4Q34597799-F0100FDC-E69A-463D-91B8-DB3E32F19B2EQ35949289-6B85747E-5370-40C8-8F4C-48901D8D7F00Q36909572-8168795B-66A8-44E1-A215-EA6E58282AF9Q37109561-53AA9F77-C935-4BFF-8292-242380F26534Q37494233-D78DED7C-3A07-4D3E-A026-57754F84EB67Q45317923-93EE8A4D-D8D3-4794-AA4E-71D7EFA18597Q45317926-3FCD6548-7E69-4FD7-A041-49329699D0ABQ47239374-5071D0ED-DF13-49E0-9340-D68C0633B300Q50297427-1332CB89-3DCF-4590-A2D3-A8849AA3F4F8Q50297428-F0574D68-1E1B-42C6-8B10-F568624E3C72Q53253609-DB591738-19B8-4729-A60F-2CF23BE2E97C
P2860
Identification and characterization of PS-GAP as a novel regulator of caspase-activated PAK-2
description
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/12/17)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/12/17)
@nl
наукова стаття, опублікована в грудні 2004
@uk
name
Identification and characteriz ...... tor of caspase-activated PAK-2
@ast
Identification and characteriz ...... tor of caspase-activated PAK-2
@en
Identification and characteriz ...... tor of caspase-activated PAK-2
@nl
type
label
Identification and characteriz ...... tor of caspase-activated PAK-2
@ast
Identification and characteriz ...... tor of caspase-activated PAK-2
@en
Identification and characteriz ...... tor of caspase-activated PAK-2
@nl
prefLabel
Identification and characteriz ...... tor of caspase-activated PAK-2
@ast
Identification and characteriz ...... tor of caspase-activated PAK-2
@en
Identification and characteriz ...... tor of caspase-activated PAK-2
@nl
P2093
P2860
P356
P1476
Identification and characteriz ...... tor of caspase-activated PAK-2
@en
P2093
Corine C. McCarthy
Erin Moertl
Mark A. Koeppel
Rolf Jakobi
P2860
P304
53653–53664
P356
10.1074/JBC.M410530200
P407
P577
2004-12-17T00:00:00Z